SBIR Presentation for Chicago Biotech Innovators: Learn about NCI’s Translational Funding Opportunities

​Recently reauthorized through FY2031, the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs provide funding opportunities and commercialization resources that early-stage biotech researchers can use to fuel their project development.

​Dr. Xing-Jian Lou, NCI SBIR Program Director, will provide a detailed overview on the program as well as highlights from reauthorization, including the new Strategic Breakthrough Award funding mechanism that provides larger, milestone-driven awards focused on technology implementation.

​Additional topics to be covered include:

• ​Recent NCI SBIR/STTR program updates

• ​New and current funding opportunities

• ​Application tips and suggestions

• ​Commercialization resources for applicants and awardees

​Following the presentation, selected attendees will have a chance to meet one-on-one in person with Dr. Lou to discuss their cancer technology project and funding eligibility.

​This presentation is appropriate for biotech researchers who are interested in advancing their life-changing innovations from lab to market.